| 臺大學術典藏 |
2022-04-15T03:14:17Z |
Clinical and functional characterization of a novel STUB1 frameshift mutation in autosomal dominant spinocerebellar ataxia type 48 (SCA48)
|
Yu S.-C.; Ko K.-Y.; SHU-CHUN TENG; Huang T.-C.; Lo H.-T.; Cheng C.-L.; Yao M.; Hong R.-L.; Chen C.-N.; Chen T.-C.; Yang T.-L. |
| 臺大學術典藏 |
2022-04-14T07:20:22Z |
Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; FENG-MING TIEN; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; Kuo S.-H.; Hong R.-L.; Huang T.-C.; Yao M. |
| 臺大學術典藏 |
2022-03-08T03:44:07Z |
A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor
|
SHIH-HUNG YANG; Lin C.-C.; Lin Z.-Z.; Tseng Y.-L.; Hong R.-L. |
| 臺大學術典藏 |
2022-03-04T06:53:40Z |
Histone methyltransferase G9a drives chemotherapy resistance by regulating the glutamate–cysteine ligase catalytic subunit in head and neck squamous cell carcinoma
|
Liu C.-W.; Hua K.-T.; Li K.-C.; Kao H.-F.; Hong R.-L.; Ko J.-Y.; Hsiao M.; Kuo M.-L.; CHING-TING TAN |
| 臺大學術典藏 |
2022-03-04T05:33:54Z |
Relation between Histological Intensity of Transforming Growth Factor-β Isoforms in Human Osteosarcoma and the Rate of Lung Metastasis
|
Yang R.-S.; CHEN-TU WU; Lin K.-H.; Hong R.-L.; Liu T.-K.; Lin K.-S. |
| 臺大學術典藏 |
2022-03-04T05:33:47Z |
Response of refractory osteosarcoma to thalidomide and celecoxib
|
Tsai Y.-C.; CHEN-TU WU; Hong R.-L. |
| 臺大學術典藏 |
2022-02-14T07:10:34Z |
A Clinicopathological Study of Cytomegalovirus Lymphadenitis and Tonsillitis and Their Association with Epstein–Barr Virus
|
SHAN-CHI YU; Ko K.-Y.; Teng S.-C.; Huang T.-C.; Lo H.-T.; Cheng C.-L.; Yao M.; Hong R.-L.; Chen C.-N.; Chen T.-C.; Yang T.-L. |
| 臺大學術典藏 |
2022-02-07T07:49:00Z |
Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; Tien F.-M.; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; SUNG-HSIN KUO; Hong R.-L.; Huang T.-C.; Yao M. |
| 臺大學術典藏 |
2022-01-12T07:07:09Z |
Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang Y.-W.; Tsai X.C.-H.; HSIN-AN HOU; Tien F.-M.; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; Kuo S.-H.; Hong R.-L.; Huang T.-C.; Yao M. |
| 臺大學術典藏 |
2021-11-18T04:58:21Z |
Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5 fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: A phase II study
|
Hong R.L; Sheen T.S; JENG-YUH KO; Hsu M.M; Wang C.C; Ting L.L. |
| 臺大學術典藏 |
2021-11-18T04:58:20Z |
DNA content of nasopharyngeal carcinoma: An independent prognostic indicator
|
Hsu M.-M; Chiou C.-R; JENG-YUH KO; Sheen T.-S; Hong R.-L; Ting L.-L. |
| 臺大學術典藏 |
2021-11-18T04:58:19Z |
Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma
|
Hong R.-L; Ting L.-L; JENG-YUH KO; Hsu M.-M; Sheen T.-S; Lou P.-J; Wang C.-C; Chung N.-N; Lui L.T. |
| 臺大學術典藏 |
2021-11-18T04:58:19Z |
Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: Experience with 60 cases
|
Hsu M.-M; Hong R.-L; Ting L.-L; JENG-YUH KO; Sheen T.-S; Lou P.-J. |
| 臺大學術典藏 |
2021-11-18T04:58:17Z |
Recent advances in the treatment of nasopharyngeal carcinoma
|
Chang J.T.-C; JENG-YUH KO; Hong R.-L. |
| 臺大學術典藏 |
2021-11-18T04:58:17Z |
Comparison of Clinical and Molecular Surveillance in Patients with Advanced Nasopharyngeal Carcinoma after Primary Therapy: The Potential Role of Quantitative Analysis of Circulating Epstein-Barr Virus DNA
|
Hong R.-L; Lin C.-Y; Ting L.-L; JENG-YUH KO; Hsu M.-M. |
| 臺大學術典藏 |
2021-11-18T04:58:06Z |
Clinicopathological features of salivary and non-salivary adenoid cystic carcinomas
|
Lin Y.-C; Chen K.-C; Lin C.-H; Kuo K.-T; JENG-YUH KO; Hong R.-L. |
| 臺大學術典藏 |
2021-11-18T04:58:05Z |
Postoperative intensity-modulated radiotherapy for squamous cell carcinoma of the external auditory canal and middle ear: Treatment outcomes, marginal misses, and perspective on target delineation
|
Chen W.-Y; Kuo S.-H; Chen Y.-H; Lu S.-H; Tsai C.-L; Chia-Hsien Cheng J; Hong R.-L; Chen Y.-F; Hsu C.-J; Lin K.-N; JENG-YUH KO; Lou P.-J; Wang C.-P; Chong F.-C; Wang C.-W. |
| 臺大學術典藏 |
2021-11-18T04:58:04Z |
Osteoradionecrosis of the upper cervical spine after radiation therapy for head and neck cancer: Differentiation from recurrent or metastatic disease with MR imaging
|
Wu L.-A; Liu H.-M; Wang C.-W; Chen Y.-F; Hong R.-L; JENG-YUH KO |
| 臺大學術典藏 |
2021-11-18T04:58:03Z |
Intensity-modulated radiation therapy for T4 nasopharyngeal carcinoma: Treatment results and locoregional recurrence
|
Chen J.L.-Y; Huang Y.-S; Kuo S.-H; Chen Y.-F; Hong R.-L; JENG-YUH KO; Lou P.-J; Tsai C.-L; Chen W.-Y; Wang C.-W. |
| 臺大學術典藏 |
2021-11-18T04:57:54Z |
Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma
|
Chen J.L; Huang Y.-S; Kuo S.-H; Hong R.-L; JENG-YUH KO; Lou P.-J; Wang C.-W. |
| 臺大學術典藏 |
2021-11-18T04:57:53Z |
Histone methyltransferase G9a drives chemotherapy resistance by regulating the glutamate�Vcysteine ligase catalytic subunit in head and neck squamous cell carcinoma
|
Liu C.-W; Hua K.-T; Li K.-C; Kao H.-F; Hong R.-L; JENG-YUH KO; Hsiao M; Kuo M.-L; Tan C.-T. |
| 臺大學術典藏 |
2021-11-18T04:57:51Z |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
|
Hong R.L; Hsiao C.F; Ting L.L; JENG-YUH KO; Wang C.W; Chang J.T.C; Lou P.J; Wang H.M; Tsai M.H; Lai S.C; Liu T.W. |
| 臺大學術典藏 |
2021-11-15T07:48:45Z |
Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5 fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: A phase II study
|
Hong R.L; Sheen T.S; JENG-YUH KO; Hsu M.M; Wang C.C; Ting L.L. |
| 臺大學術典藏 |
2021-11-15T07:48:43Z |
Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: Experience with 60 cases
|
Hsu M.-M; Hong R.-L; Ting L.-L; JENG-YUH KO; Sheen T.-S; Lou P.-J. |
| 臺大學術典藏 |
2021-11-15T07:48:43Z |
DNA content of nasopharyngeal carcinoma: An independent prognostic indicator
|
Hsu M.-M; Chiou C.-R; JENG-YUH KO; Sheen T.-S; Hong R.-L; Ting L.-L. |
| 臺大學術典藏 |
2021-11-15T07:48:42Z |
Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma
|
Hong R.-L; Ting L.-L; JENG-YUH KO; Hsu M.-M; Sheen T.-S; Lou P.-J; Wang C.-C; Chung N.-N; Lui L.T. |
| 臺大學術典藏 |
2021-11-15T07:48:41Z |
Comparison of Clinical and Molecular Surveillance in Patients with Advanced Nasopharyngeal Carcinoma after Primary Therapy: The Potential Role of Quantitative Analysis of Circulating Epstein-Barr Virus DNA
|
Hong R.-L; Lin C.-Y; Ting L.-L; JENG-YUH KO; Hsu M.-M. |
| 臺大學術典藏 |
2021-11-15T07:48:40Z |
Recent advances in the treatment of nasopharyngeal carcinoma
|
Chang J.T.-C; JENG-YUH KO; Hong R.-L. |
| 臺大學術典藏 |
2021-11-15T07:48:28Z |
Clinicopathological features of salivary and non-salivary adenoid cystic carcinomas
|
Lin Y.-C; Chen K.-C; Lin C.-H; Kuo K.-T; JENG-YUH KO; Hong R.-L. |
| 臺大學術典藏 |
2021-11-15T07:48:27Z |
Postoperative intensity-modulated radiotherapy for squamous cell carcinoma of the external auditory canal and middle ear: Treatment outcomes, marginal misses, and perspective on target delineation
|
Chen W.-Y; Kuo S.-H; Chen Y.-H; Lu S.-H; Tsai C.-L; Chia-Hsien Cheng J; Hong R.-L; Chen Y.-F; Hsu C.-J; Lin K.-N; JENG-YUH KO; Lou P.-J; Wang C.-P; Chong F.-C; Wang C.-W. |
| 臺大學術典藏 |
2021-11-15T07:48:26Z |
Osteoradionecrosis of the upper cervical spine after radiation therapy for head and neck cancer: Differentiation from recurrent or metastatic disease with MR imaging
|
Wu L.-A; Liu H.-M; Wang C.-W; Chen Y.-F; Hong R.-L; JENG-YUH KO |
| 臺大學術典藏 |
2021-11-15T07:48:25Z |
Intensity-modulated radiation therapy for T4 nasopharyngeal carcinoma: Treatment results and locoregional recurrence
|
Chen J.L.-Y; Huang Y.-S; Kuo S.-H; Chen Y.-F; Hong R.-L; JENG-YUH KO; Lou P.-J; Tsai C.-L; Chen W.-Y; Wang C.-W. |
| 臺大學術典藏 |
2021-11-15T07:48:15Z |
Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma
|
Chen J.L; Huang Y.-S; Kuo S.-H; Hong R.-L; JENG-YUH KO; Lou P.-J; Wang C.-W. |
| 臺大學術典藏 |
2021-11-15T07:48:14Z |
Histone methyltransferase G9a drives chemotherapy resistance by regulating the glutamate�Vcysteine ligase catalytic subunit in head and neck squamous cell carcinoma
|
Liu C.-W; Hua K.-T; Li K.-C; Kao H.-F; Hong R.-L; JENG-YUH KO; Hsiao M; Kuo M.-L; Tan C.-T. |
| 臺大學術典藏 |
2021-11-15T07:48:12Z |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
|
Hong R.L; Hsiao C.F; Ting L.L; JENG-YUH KO; Wang C.W; Chang J.T.C; Lou P.J; Wang H.M; Tsai M.H; Lai S.C; Liu T.W. |
| 臺大學術典藏 |
2021-10-25T02:57:44Z |
Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5 fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: A phase II study
|
Hong R.L; |Sheen T.S; |JENG-YUH KO; |Hsu M.M; |Wang C.C; |Ting L.L. |
| 臺大學術典藏 |
2021-10-25T02:57:41Z |
Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma
|
Hong R.-L; |Ting L.-L; |JENG-YUH KO; |Hsu M.-M; |Sheen T.-S; |Lou P.-J; |Wang C.-C; |Chung N.-N; |Lui L.T. |
| 臺大學術典藏 |
2021-10-25T02:57:40Z |
Comparison of Clinical and Molecular Surveillance in Patients with Advanced Nasopharyngeal Carcinoma after Primary Therapy: The Potential Role of Quantitative Analysis of Circulating Epstein-Barr Virus DNA
|
Hong R.-L; |Lin C.-Y; |Ting L.-L; |JENG-YUH KO; |Hsu M.-M. |
| 臺大學術典藏 |
2021-10-25T02:57:11Z |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
|
Hong R.L; |Hsiao C.F; |Ting L.L; |JENG-YUH KO; |Wang C.W; |Chang J.T.C; |Lou P.J; |Wang H.M; |Tsai M.H; |Lai S.C; |Liu T.W. |
| 臺大學術典藏 |
2021-09-01T02:02:46Z |
Use of retinoic acids in the treatment of peripheral T-cell lymphoma: A pilot study
|
ANN-LII CHENG; Su I.-J.; Chen C.-C.; Tien H.-F.; Lay J.-D.; Chen B.-R.; Pu Y.-S.; Hong R.-L.; Shen M.-C.; Wang C.-H.; Chen Y.-C. |
| 臺大學術典藏 |
2021-09-01T02:02:44Z |
Clinicopathologic characteristics of helicobacter pyloric seropositive gastric adenocarcinomas
|
Lee W.-J.; Lin J.-T.; Lee W.C.; Shun C.-T.; Hong R.-L.; ANN-LII CHENG; Lee P.-H.; Wei T.-C.; Chen K.-M. |
| 臺大學術典藏 |
2021-09-01T02:02:40Z |
A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers
|
Yeh K.-H.; ANN-LII CHENG; Lin M.-T.; Hong R.-L.; Hsu C.-H.; Lin J.-F.; Chang K.-J.; Lee P.-H.; Chen Y.-C. |
| 臺大學術典藏 |
2021-09-01T02:02:40Z |
MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer
|
Hsu C.; Yeh K.-H.; Hong R.-L.; Yang C.-H.; Lin M.-T.; Chen Y.-C.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:29Z |
Prognostic value of multidrug resistance 1, glutathione-S-transferase-π and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy
|
Hsu C.-H.; Chen C.-L.; Hong R.-L.; Chen K.-L.; Lin J.-F.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:11Z |
Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: Implication from age-period-cohort analysis
|
Hsu C.; Shen Y.-C.; Cheng C.-C.; Hong R.-L.; Chang C.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:29:41Z |
Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma
|
Yang C.W.-C.; Wang C.-W.; Hong R.-L.; Tsai C.-L.; Yao M.; Tang J.-L.; Lin C.-W.; ANN-LII CHENG; Kuo S.-H. |
| 臺大學術典藏 |
2021-08-12T04:01:31Z |
A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor
|
YANG SHIH-HUNG; Lin C.-C.; Lin Z.-Z.; Tseng Y.-L.; Hong R.-L. |
| 臺大學術典藏 |
2021-08-11T03:46:48Z |
A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor
|
Yang S.-H.; Lin C.-C.; ZHONG-ZHE LIN; Tseng Y.-L.; Hong R.-L. |
| 臺大學術典藏 |
2021-08-11T03:46:46Z |
Factors impacting prognosis prediction in BCLC stage C and Child-Pugh Class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy
|
ZHONG-ZHE LIN; Hsu C.; Hu F.-C.; Shao Y.-Y.; Chang D.-Y.; Yang C.-H.; Hong R.-L.; Hsu C.-H.; Chengb A.-L. |
| 臺大學術典藏 |
2021-08-10T03:53:07Z |
A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor
|
SHIH-HUNG YANG; Lin C.-C.; Lin Z.-Z.; Tseng Y.-L.; Hong R.-L. |
